Advertisement

Vitamin E and Muscle Diseases

  • M. J. Jackson
  • D. A. Jones
  • R. H. T. Edwards

Abstract

Studies of the basic biochemical mechanisms underlying muscle damage aimed at finding agents which might reduce the amount of damage occurring in muscular dystrophy and other severe myopathies have been performed. These have suggested three types of agent which might be useful for this purpose, namely calcium antagonists, phospholipase inhibitors, and antioxidants or scavengers of reactive-free radicals. Vitamin E falls into the latter of these three categories and has been shown to reduce the amount of damage which occurs in isolated skeletal muscles following a given stress. It is suggested that, in the absence of calcium antagonists having relatively specific and effective actions on skeletal muscle or suitable inhibitors of muscle phospholipases in man, therapy with vitamin E or other antioxidants may reduce the amount of muscle damage occurring in patients with severe myopathies.

Keywords

Muscular Dystrophy Muscle Damage Duchenne Muscular Dystrophy Phospholipase Activity Calcium Ionophore A23187 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Bertorini, T. E., Bhattacharya, S. K., Palmieri, G. M. A., Chesney, C. M., Pifer, D. and Baker, B. Muscle calcium and magnesium content in Duchenne muscular dystrophy. Neurology 32 (1982) 1088–1092PubMedGoogle Scholar
  2. Bicknell, F. Vitamin E in the treatment of muscular dystrophies and nervous diseases. Lancet i (1940) 10–13CrossRefGoogle Scholar
  3. Bodenstein, J. B. and Engel, A. G. Intracellular calcium accumulation in Duchenne dystrophy and other myopathies: a study of 567000 muscle fibres in 114 biopsies. Neurology 28 (1978) 439–446Google Scholar
  4. Dawson, D. M. Efflux of enzymes from chicken muscle. Biochim. Biophys. Acta 113 (1966) 144–157PubMedGoogle Scholar
  5. Diplock, A. T. The modulating influence of vitamin E in biological membrane unsaturated phospholipid metabolism. Acta Vit. Enzymol. 4 (1982) 303–309Google Scholar
  6. Duncan, C. J. Role of intracellular calcium in promoting muscle damage: a strategy for controlling the dystrophic condition. Experientia 34 (1978) 1531–1535PubMedCrossRefGoogle Scholar
  7. Edwards, R. H. T., Jones, D. A. and Jackson, M. J. An approach to treatment trials in muscular dystrophy with particular reference to agents influencing free radial damage. Med. Biol. 62 (1984) 143–147PubMedGoogle Scholar
  8. Fitzgerald, G. and McArdle, B. Vitamin E and B6 in the treatment of muscular dystrophy and motor neurone disease. Brain 64 (1941) 19–42CrossRefGoogle Scholar
  9. Guarnieri, C., Ferrari, R., Visioli, O., Caldarera, C. M. and Nayler, W. G. Effect of α-tocopherol on hypoxic-perfused and reoxygenated rabbit heart muscle. J. Molec. Cell Cardiol. 10 (1978) 893–906CrossRefGoogle Scholar
  10. Gutteridge, J. M. C. The effect of calcium on phospholipid peroxidation. Biochem. Biophys. Commun. 74 (1977) 529–537CrossRefGoogle Scholar
  11. Jackson, M. J., Jones, D. A. and Edwards, R. H. T. Vitamin E and skeletal muscle. In Ciba Foundation Symposium Series No. 101. Biology of Vitamin E, Pitman Press, London, 1983, pp. 224–239Google Scholar
  12. Jackson, M. J., Jones, D. A. and Edwards, R. H. T. Techniques for studying free radical damage in muscular dystrophy. Med. Biol. 62 (1984a) 135–138PubMedGoogle Scholar
  13. Jackson, M. J., Jones, D. A. and Edwards, R. H. T. Experimental skeletal muscle damage: the nature of the calcium-activated degenerative processes. Eur. J. Clin. Invest. 14 (1984b) 366–374CrossRefGoogle Scholar
  14. Jain, S. K. and Shohet, S. B. Calcium potentiates the peroxidation of erythrocyte membrane lipids. Biochim. Biophys. Acta 642 (1981) 46–54PubMedCrossRefGoogle Scholar
  15. Jones, D. A., Jackson, M. J. and Edwards, R. H. T. Release of intracellular enzymes from an isolated mammalian skeletal muscle preparation. Clin. Sci. 65 (1983) 193–201PubMedGoogle Scholar
  16. Jones, D. A., Jackson, M. J., McPhail, G. and Edwards, R. H. T. Experimental mouse muscle damage: the importance of external calcium. Clin. Sci. 66 (1984) 317–322PubMedGoogle Scholar
  17. Maunder-Sewry, C. A., Gorodetsky, R., Yaron, R. and Dubowitz, V. Elemental analysis of skeletal muscle in Duchenne muscular dystrophy using X-ray fluorescence spectrometry. Muscle and Nerve 3 (1980) 502–508PubMedCrossRefGoogle Scholar
  18. Muller, D. P. R., Lloyd, J. K. and Wolf, O. H. Vitamin E and neurological function: abetalipoproteinaemia and other disorders of fat absorption. In Ciba Foundation Symposium Series No. 101. Biology of Vitamin E, Pitman Press, London, 1983, pp. 106–121Google Scholar
  19. Publicover, S. J., Duncan, C. J. and Smith, J. L. The use of A23187 to demonstrate the role of intracellular calcium in causing ultrastructural damage in mammalian muscle. J. Neuropath. Exp. Neurol. 37 (1978) 544–557CrossRefGoogle Scholar
  20. Quintanilha, A. T. and Packer, L. Vitamin E, physical exercise and tissue oxidative damage. In Ciba Foundation Symposium Series No. 101. Biology of Vitamin E, Pitman Press, London, 1983, pp. 56–69Google Scholar
  21. Rodemann, H. P., Waxman, L. and Goldberg, A. L. The stimulation of protein degradation in muscle by Ca2+ is mediated by prostaglandin E2 and does not require the calcium activated protease. J. Biol. Chem. 257 (1981) 8716–8723Google Scholar
  22. Soybell, D., Morgan, J. and Cohen, L. Calcium augmentation of enzyme leakage from mouse skeletal muscle and its possible site of action. Res. Commun. Chem. Pathol. Pharmacol. 20 (1978) 317–329Google Scholar
  23. Suarez-Kurtz, G. and Eastwood, A. B. Release of sarcoplasmic enzymes from frog skeletal muscle. Am. J. Physiol. 241 (1981) C98–C105PubMedGoogle Scholar
  24. Tappel, L. Vitamin E as the biological lipid antioxidant. Vitamins and Hormones 20 (1962) 493–510CrossRefGoogle Scholar
  25. Walton, J. N. and Nattrass, F. J. On the classification, natural history and treatment of the myopathies. Brain 77 (1954) 169–231PubMedCrossRefGoogle Scholar

Copyright information

© SSIEM and MTP Press Limited 1985

Authors and Affiliations

  • M. J. Jackson
    • 1
  • D. A. Jones
    • 1
  • R. H. T. Edwards
    • 1
  1. 1.Department of MedianeUniversity College London School of Medicine, The Rayne InstituteLondonUK

Personalised recommendations